Clinical Trial 22095

• Overview

  Study Title:

  A Phase 2 study of Canakinumab in patients with Myelofibrosis

• Treatments

  Therapies:

  Immunotherapy

  Medications:

  Canakinumab ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.